Brain tumor stem cells.
The concept of brain tumor stem cells is gaining increased recognition in neuro-oncology. Until recently, the paradigm of a tumor-initiating stem cell was confined to hematopoietic malignancies where the hierarchical lineages of stem progenitor cells are well established. The demonstration of persistent stem cells and cycling progenitors in the adult brain, coupled with the expansion of the cancer stem cell concept to solid tumors, has led to the exploration of "stemness" within gliomas. Emerging data are highly suggestive of the subsistence of transformed multipotential cells within a glioma, with a subfraction of cells exhibiting increased efficiency at tumor initiation. However, data in support of true glioma stem cells are inconclusive to date, particularly with respect to functional characterization of these cells. Ongoing work aims at the identification of unique pathways governing self-renewal of these putative stem cells and at their validation as ultimate therapeutic targets.
Panagiotakos
Georgia
G
Division of Neurosurgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, C711, New York, NY 10021, USA.
Tabar
Viviane
V
D000818:Animals; D001932:Brain Neoplasms / Q000473:pathology*; D002454:Cell Differentiation; D002471:Cell Transformation, Neoplastic; D006801:Humans; D014411:Neoplastic Stem Cells / Q000166:cytology / Q000502:physiology*